Pharma Industry News Advanced Accelerator Applications receives FDA approval for Lutathera® for treatment of gastroenteropancreatic neuroendocrine tumors 7 years ago
Pharma Industry News Santhera’s Raxone rejected in Europe for Duchenne muscular dystrophy 7 years ago